Related Experiment Video
Updated: Dec 9, 2025

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
Published on: October 29, 2012
Pathways for nicotinic receptor desensitization
1Department of Physiology and Biophysics, State University of New York at Buffalo, Buffalo, NY.
Nicotinic acetylcholine receptors (AChRs) desensitize via distinct pathways depending on agonist presence. Two models, the "prism" and "monkey saddle," explain these differing desensitization and recovery pathways.
Area of Science:
- Neuroscience
- Molecular Biology
- Biophysics
Background:
- Nicotinic acetylcholine receptors (AChRs) are ligand-gated ion channels crucial for neurotransmission.
- AChRs exhibit desensitization, a process where channel activity diminishes despite agonist presence.
- Understanding the distinct pathways for AChR desensitization and recovery remains a long-standing challenge.
Purpose of the Study:
- To discuss two proposed mechanisms explaining the differential pathways of AChR desensitization and recovery.
- To explore how ligands influence the selection between desensitization and recovery pathways.
- To consider experimental approaches for distinguishing between the proposed mechanisms.
Main Methods:
- Theoretical discussion of two models: a discrete-state model (prism) and a potential energy surface model (monkey saddle).
- Analysis of kinetic and thermodynamic principles governing receptor conformational changes.
- Consideration of ligand-specific energy properties (φ values) and transition state shifts.
Main Results:
- The 'prism' model suggests distinct pathways due to ligand-dependent energy properties at transition states.
- The 'monkey saddle' model proposes agonist-induced shifts in gating transition states influence pathway selection.
- Both models indicate that desensitization pathway selection is primarily a kinetic, rather than thermodynamic, phenomenon.
Conclusions:
- Two distinct models offer explanations for the observed differences in AChR desensitization and recovery pathways.
- The choice of pathway appears to be governed by kinetic factors influenced by ligand binding.
- Further experiments are needed to experimentally differentiate between the 'prism' and 'monkey saddle' models.
Related Concept Videos
Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
GPCR Desensitization
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Desensitization and Tachyphylaxis
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Neurochemical Transmission: Sites of Drug Action

